Rifampin drastically reduces plasma concentrations and effects of oral midazolam (Q51584849)

7 April 2018

title

Rifampin drastically reduces plasma concentrations and effects of oral midazolam (English)

1 reference

7 April 2018

1 reference

Backman JT

1 reference

7 April 2018

Olkkola KT

series ordinal

1 reference

7 April 2018

Neuvonen PJ

series ordinal

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 January 1996

1 reference

7 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 April 2018

volume

1 reference

7 April 2018

issue

1 reference

7 April 2018

page(s)

7-13

1 reference

7 April 2018

Dose of midazolam should be reduced during diltiazem and verapamil treatments

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Pencil and paper tests-sensitivity to psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

A potentially hazardous interaction between erythromycin and midazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

In vitro forecasting of drugs which may interfere with the biotransformation of midazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Pharmacokinetic drug interactions with rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects?A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Measurement of Recovery from Outpatient General Anaesthesia with a Simple Ocular Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

The use of analogue scales in rating subjective feelings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Extrahepatic metabolism of drugs in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

The erythromycin breath test predicts the clearance of midazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990018-1

10.1016/S0009-9236(96)90018-1

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018